De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Advanced Medical Solutions Group Beheer
Beheer criteriumcontroles 4/4
De CEO Advanced Medical Solutions Group's is Chris Meredith, benoemd in Jan2011, heeft een ambtstermijn van 13.75 jaar. De totale jaarlijkse vergoeding van { bedraagt £ 813.00K, bestaande uit 46.6% salaris en 53.4% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.83% van de aandelen van het bedrijf, ter waarde £ 3.90M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.8 jaar en 3.7 jaar.
Belangrijke informatie
Chris Meredith
Algemeen directeur
UK£813.0k
Totale compensatie
| Percentage CEO-salaris | 46.6% |
| Dienstverband CEO | 13.8yrs |
| Eigendom CEO | 0.8% |
| Management gemiddelde ambtstermijn | 5.8yrs |
| Gemiddelde ambtstermijn bestuur | 3.7yrs |
Recente managementupdates
Recent updates
A Look At The Fair Value Of Advanced Medical Solutions Group plc (LON:AMS)
Sep 07
Should You Be Adding Advanced Medical Solutions Group (LON:AMS) To Your Watchlist Today?
Nov 03Advanced Medical Solutions Group plc (LON:AMS) Shares Could Be 38% Below Their Intrinsic Value Estimate
Sep 05Advanced Medical Solutions Group (LON:AMS) Will Want To Turn Around Its Return Trends
Dec 03Are Investors Undervaluing Advanced Medical Solutions Group plc (LON:AMS) By 23%?
Sep 03Advanced Medical Solutions Group's (LON:AMS) Returns On Capital Not Reflecting Well On The Business
Aug 05An Intrinsic Calculation For Advanced Medical Solutions Group plc (LON:AMS) Suggests It's 33% Undervalued
May 31Advanced Medical Solutions Group (LON:AMS) May Have Issues Allocating Its Capital
Apr 23Advanced Medical Solutions Group (LON:AMS) Might Be Having Difficulty Using Its Capital Effectively
Jan 08A Look At The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Nov 24Some Investors May Be Worried About Advanced Medical Solutions Group's (LON:AMS) Returns On Capital
May 22A Look At The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Apr 10Results: Advanced Medical Solutions Group plc Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 20Should Advanced Medical Solutions Group (LON:AMS) Be Disappointed With Their 30% Profit?
Feb 28The Returns At Advanced Medical Solutions Group (LON:AMS) Provide Us With Signs Of What's To Come
Feb 07
Advanced Medical Solutions Group plc's (LON:AMS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jan 18How Much Is Advanced Medical Solutions Group plc (LON:AMS) Paying Its CEO?
Dec 28Calculating The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Dec 10The Advanced Medical Solutions Group (LON:AMS) Share Price Is Up 38% And Shareholders Are Holding On
Nov 20Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | UK£11m |
| Mar 31 2024 | n/a | n/a | UK£14m |
| Dec 31 2023 | UK£813k | UK£379k | UK£16m |
| Sep 30 2023 | n/a | n/a | UK£18m |
| Jun 30 2023 | n/a | n/a | UK£20m |
| Mar 31 2023 | n/a | n/a | UK£20m |
| Dec 31 2022 | UK£832k | UK£339k | UK£20m |
| Sep 30 2022 | n/a | n/a | UK£19m |
| Jun 30 2022 | n/a | n/a | UK£18m |
| Mar 31 2022 | n/a | n/a | UK£18m |
| Dec 31 2021 | UK£543k | UK£329k | UK£17m |
| Sep 30 2021 | n/a | n/a | UK£16m |
| Jun 30 2021 | n/a | n/a | UK£14m |
| Mar 31 2021 | n/a | n/a | UK£11m |
| Dec 31 2020 | UK£537k | UK£305k | UK£9m |
| Sep 30 2020 | n/a | n/a | UK£11m |
| Jun 30 2020 | n/a | n/a | UK£14m |
| Mar 31 2020 | n/a | n/a | UK£16m |
| Dec 31 2019 | UK£770k | UK£300k | UK£19m |
| Sep 30 2019 | n/a | n/a | UK£20m |
| Jun 30 2019 | n/a | n/a | UK£21m |
| Mar 31 2019 | n/a | n/a | UK£22m |
| Jan 01 2019 | n/a | n/a | UK£22m |
| Sep 30 2018 | n/a | n/a | UK£22m |
| Jun 30 2018 | n/a | n/a | UK£22m |
| Mar 31 2018 | n/a | n/a | UK£21m |
| Dec 31 2017 | UK£1m | UK£270k | UK£20m |
Compensatie versus markt: De totale vergoeding ($USD 1.08M ) Chris } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de UK markt ($USD 1.42M ).
Compensatie versus inkomsten: De vergoeding van Chris is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Chris Meredith (58 yo)
13.8yrs
Tenure
UK£813,000
Compensatie
Mr. Andrew Christopher Meredith, also known as Chris, B.Sc. (Hons.) has been the Chief Executive Officer of Advanced Medical Solutions Group plc since January 2011 and served as Chief Operating Officer sin...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Executive Director | 13.8yrs | UK£813.00k | 0.83% £ 3.8m | |
| CFO & Executive Director | 5.8yrs | UK£415.00k | 0.070% £ 324.0k | |
| Group Operations Director | less than a year | geen gegevens | geen gegevens | |
| Investor Relations Manager | no data | geen gegevens | geen gegevens | |
| Head of Legal | no data | geen gegevens | geen gegevens | |
| Group Human Resources Director | 7.4yrs | geen gegevens | geen gegevens | |
| Company Secretary | 3.8yrs | geen gegevens | geen gegevens |
5.8yrs
Gemiddelde duur
Ervaren management: Het managementteam van AMS is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Executive Director | 18.5yrs | UK£813.00k | 0.83% £ 3.8m | |
| CFO & Executive Director | 5.8yrs | UK£415.00k | 0.070% £ 324.0k | |
| Senior Independent Non-Executive Director | 3.7yrs | UK£57.00k | geen gegevens | |
| Independent Non-Executive Director | 3.2yrs | UK£54.00k | geen gegevens | |
| Independent Non-Executive Chairman | 2.2yrs | UK£46.00k | 0.025% £ 116.2k |
3.7yrs
Gemiddelde duur
58yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van AMS wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.7 jaar).